• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harpoon Therapeutics, Inc. - Common Stock (NQ:HARP)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 23.00 (6)
Ask (Size) 23.01 (36)
Prev. Close 23.01
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 37,595,787
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Analyst Scoreboard: 4 Ratings For Harpoon Therapeutics ↗
February 26, 2024
 
Via Benzinga
Harpoon Therapeutics Inc. (NASDAQ: HARP) Records 52-Week High Thursday Morning
February 22, 2024
Via Investor Brand Network

Performance

More News

Read More
News headline image
Merck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growth ↗
February 01, 2024
Via Benzinga
News headline image
Investor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earnings ↗
January 29, 2024
Via Benzinga
News headline image
This 1 Bullish Move by Merck Could Drive Growth for Years to Come ↗
January 23, 2024
Via The Motley Fool
News headline image
The 3 Best Dividend Growth Stocks to Buy in January 2024 ↗
January 17, 2024
Via InvestorPlace
News headline image
Peeling Back The Layers: Exploring Harpoon Therapeutics Through Analyst Insights ↗
January 16, 2024
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗
January 12, 2024
Via Investor's Business Daily
Topics ETFs
News headline image
HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARP
January 10, 2024
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results ↗
January 08, 2024
Via Benzinga
Topics Stocks
News headline image
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
January 08, 2024
Via Benzinga
Harpoon Therapeutics Inc. (NASDAQ: HARP) Near the Top of Equities by Percentage Gain on 1/8
January 08, 2024
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
January 08, 2024
Via Benzinga
News headline image
Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher ↗
January 08, 2024
Via Benzinga
Topics Stocks
News headline image
Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal ↗
January 08, 2024
Via Benzinga
News headline image
Health Care Company Merck & Co Announces Acquisition of Harpoon Therapeutics ↗
January 08, 2024
Via Benzinga
News headline image
US Stocks Mixed; Nasdaq Jumps Over 100 Points ↗
January 08, 2024
Via Benzinga
Topics Stocks
News headline image
Merck, the Dow's hottest stock, gets set to report Q4 financials
January 08, 2024
Via MarketBeat
Topics Stocks
News headline image
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value ↗
January 08, 2024
Via Investor's Business Daily
News headline image
Why Is Spirit AeroSystems (SPR) Stock Down 14% Today? ↗
January 08, 2024
Via InvestorPlace
News headline image
Why Is LumiraDx (LMDX) Stock Down 13% Today? ↗
January 08, 2024
Via InvestorPlace
News headline image
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today? ↗
January 08, 2024
Via InvestorPlace
News headline image
HARP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Harpoon Therapeutics, Inc. Is Fair to Shareholders
January 08, 2024
From Halper Sadeh LLC
Via Business Wire

Frequently Asked Questions

Is Harpoon Therapeutics, Inc. - Common Stock publicly traded?
Yes, Harpoon Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Harpoon Therapeutics, Inc. - Common Stock trade on?
Harpoon Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harpoon Therapeutics, Inc. - Common Stock?
The ticker symbol for Harpoon Therapeutics, Inc. - Common Stock is HARP on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap